Skip to main content
Clinical Trials/NCT03937375
NCT03937375
Completed
Not Applicable

Re-Evaluation of the Effects of High PEEP During General Anesthesia For Surgery - An Individual Patient Data Meta-Analysis of PROVHILO, iPROVE and PROBESE

Hospital Israelita Albert Einstein3 sites in 3 countries3,837 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgery
Sponsor
Hospital Israelita Albert Einstein
Enrollment
3837
Locations
3
Primary Endpoint
Incidence of postoperative pulmonary complications
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Aiming to understand the isolated impact of high PEEP in patients undergoing mechanical ventilation for general anesthesia for surgery, three appropriately sized international multicentre randomized controlled trials have been performed over recent years: the 'PROtective Ventilation using HIgh versus LOw PEEP trial (PROVHILO), the 'individualized PeRioperative Open-lung Ventilation trial' (iPROVE), and the 'Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients trial' (PROBESE). These three trials had several similarities in key areas of their study protocols, inclusion and exclusion criteria, and collected data, and even the primary and secondary outcomes. Of note, the three trials combined high PEEP with recruitment manoeuvres. This allows an individual patient data meta-analysis.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
January 30, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Enrolled into one of the three studies (PROVHILO, iPROVE or PROBESE) to either high PEEP or low PEEP

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of postoperative pulmonary complications

Time Frame: Until day seven or hospital discharge, whichever comes first

Collapsed composite of complications developing within the first seven postoperative days, including: Mild respiratory failure; or Severe respiratory failure; or Acute Respiratory Distress Syndrome (ARDS); or Pulmonary infection; or Pleural effusion; or Atelectasis; or Pneumothorax; or Bronchospasm.

Secondary Outcomes

  • Incidence of extrapulmonary pulmonary complications(Until day seven or hospital discharge, whichever comes first)
  • Incidence of intraoperative complications(Intraoperatively)
  • Incidence of severe postoperative pulmonary complications(Until day seven or hospital discharge, whichever comes first)
  • Incidence of intensive care unit admission(Until hospital discharge, death or 100 days, whichever comes first)
  • Hospital length of stay(Until hospital discharge, death or 100 days, whichever comes first)
  • Incidence of 7-day mortality(Until day seven or hospital discharge, whichever comes first)
  • Incidence of in-hospital mortality(Until hospital discharge, death or 100 days, whichever comes first)
  • Incidence of major postoperative complications(Until day seven or hospital discharge, whichever comes first)

Study Sites (3)

Loading locations...

Similar Trials